Close
Xylem
Novotech

Press Releases

DFE Pharma, Harro Hofliger, and Sterling partner in INTO to provide formulation services for respiratory products

Three leading companies in their respective fields - DFE Pharma (excipients solution provider), Harro Hรถfliger (equipment supplier), and Sterling (API manufacturer) - announced a unique partnership with the establishment of โ€œInhalation Togetherโ€ (INTO) in the field of dry powder...

Oasmia Signs Manufacturing Agreement with Lonza for Ovarian Cancer Drug Candidate Cantrixil

Oasmia Pharmaceutical AB, an oncology-focused specialty pharmaceutical company, and Lonza, a global development and manufacturing partner to the pharma, biotech and nutrition industries, announced that the companies have signed a large-scale manufacturing agreement for the main drug intermediate in...

SEQENS Makes Multi-Million-Dollar Investment in U.S. R&D Laboratory

SEQENS, an integrated leader in the manufacturing of active ingredients and pharmaceutical intermediates, announced a multi-million-dollar investment in its research and development laboratory located in Devens, Mass. The improvements will ensure that the new facility will operate at the...

Phlow to Provide Manufacturing R&D Services for Small Molecule Pharmaceutical Product Development in the Commercial Sector

Phlow Corp., a U.S.-based essential medicines public benefit company, announced strategic alliances with both Virginia Commonwealth Universityโ€™s (VCU) Medicines for All Institute and AMPAC Fine Chemicals to provide contract continuous manufacturing research and development (R&D) services for small molecule...

Sen-Jam Pharm Partners with Specialty Pharma Manufacturer to Provide Formulation and Chemistry, Manufacturing & Controls for Covid-19 Oral Therapeutic

Sen-Jam Pharmaceutical, an innovative life sciences company developing a portfolio of revolutionary anti-inflammatories by repurposing existing molecules for novel combination therapy, has entered a strategic partnership with KVK Tech. KVK Tech is a leading Specialty Pharmaceutical Manufacturing company that...

Gamma Biosciences Launches Initiative Through Mirus Bio to Develop Lipid-Polymer Nanocomplexes for In Vivo mRNA Delivery

Gamma Biosciences, a global life sciences company serving the advanced therapy market, announced an initiative through its subsidiary Mirus Bio, a leader in nucleic acid delivery technology, to develop novel, highly active lipid-polymer nanocomplexes for therapeutic mRNA delivery in...

Pfizer to supply UNICEF up to 4 million treatment courses of novel Covid-19 oral treatment, Paxlovid for low- and middle-income countries

Pfizer Inc. announced an agreement with UNICEF to supply up to 4 million treatment courses of its Covid-19 oral treatment, Paxlovid (nirmatrelvir tablets and ritonavir tablets), to 95 low- and middle-income countries, pending authorization or approval. This includes...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate ยป